Ken Griffin MARINUS PHARMACEUTICALS INC Transaction History

Citadel Advisors LLC

34,500

Previous 73,700 53.19%

Previous $0 NaN%

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	N/A	236,840 Added 6643.48%	240,405 $0
Q2 2024 Aug 14, 2024	SELL	N/A	-1,240,275 Reduced 99.71%	3,565 $0
Q1 2024 May 15, 2024	BUY	N/A	647,444 Added 108.56%	1,243,840 $0
Q4 2023 Feb 14, 2024	BUY	N/A	118,387 Added 24.77%	596,396 $0
Q3 2023 Nov 14, 2023	BUY	N/A	175,697 Added 58.12%	478,009 $0
Q2 2023 Aug 14, 2023	BUY	N/A	118,904 Added 64.83%	302,312 $0
Q1 2023 May 15, 2023	SELL	N/A	-169,045 Reduced 47.96%	183,408 $0
Q4 2022 Feb 14, 2023	BUY	N/A	120,625 Added 52.03%	352,453 $0
Q3 2022 Nov 14, 2022	BUY	N/A	12,338 Added 5.62%	231,828 $1.54 Million
Q2 2022 Aug 15, 2022	BUY	N/A	191,640 Added 688.11%	219,490 $1.06 Million
Q1 2022 May 16, 2022	SELL	N/A	-196,490 Reduced 87.59%	27,850 $261,000
Q4 2021 Feb 14, 2022	BUY	N/A	172,888 Added 336.02%	224,340 $0
Q3 2021 Nov 15, 2021	SELL	N/A	-163,563 Reduced 76.07%	51,452 $585,000
Q2 2021 Aug 16, 2021	BUY	N/A	185,724 Added 634.07%	215,015 $0
Q1 2021 May 17, 2021	SELL	N/A	-22,737 Reduced 43.7%	29,291 $453,000
Q3 2020 Nov 16, 2020	BUY	N/A	52,028 New	52,028 $668,000

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.